Intravenous radionuclide therapy with radium chloride [223Ra] in patients with bone metastases from castration-resistant prostate cancer

Intravenous radionuclide therapy with radium chloride [223Ra] in patients with bone metastases from castration-resistant prostate cancer

Purpose of the study. Assessment of clinical safety and effectiveness of radium‑223 in patients with bone metastases from castration-resistant prostate cancer.Patients and methods. The study involved materials on 15 patients with bone metastases from castration-resistant prostate cancer aged 58–81 y...

Full description

Saved in:
Bibliographic Details
Main Authors: O. I. Kit, N. A. Maksimova, M. A. Gusareva, A. N. Shevchenko, M. S. Zinkovich, M. G. Ilchenko, K. P. Boyko, A. V. Faenson, S. N. Dimitriadi, L. Ya. Rozenko
Format: Article
Language:Russian
Published: ANO "Perspective of oncology" 2024-12-01
Series:Южно-Российский онкологический журнал
Subjects:
castration-resistant prostate cancer
bone metastases
radium chloride [223ra]
quality of life
Online Access:https://www.cancersp.com/jour/article/view/272
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.cancersp.com/jour/article/view/272

Similar Items